Statistics for A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
Total visits
| views | |
|---|---|
| A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season | 143 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
File Visits
| views | |
|---|---|
| A phase 2, randomized double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab.pdf | 4 |
Top country views
| views | |
|---|---|
| United States | 48 |
| Chile | 30 |
| Germany | 9 |
| China | 7 |
| Sweden | 5 |
| Finland | 2 |
| Mexico | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 25 |
| Alameda | 7 |
| Concepcion | 5 |
| Beijing | 4 |
| Åkersberga | 4 |
| Balingen | 1 |
| Campbell | 1 |
| Hanoi | 1 |
| Jacksonville | 1 |
| Kempen | 1 |
| Louisville | 1 |
| Sacramento | 1 |
| Stockholm | 1 |
| Zapopan | 1 |